Sonnet Biotherapeutics Holdings Inc - ESG Rating & Company Profile powered by AI
Jump to the bottom of this page for potential risks for Sonnet Biotherapeutics Holdings Inc based on industry, geography and size. If you are employed by Sonnet Biotherapeutics Holdings Inc and you would like to use your Sustainability aseessment, please get in touch. This webpage displays a zero-cost Sustainability analysis for Sonnet Biotherapeutics Holdings Inc.
Sonnet Biotherapeutics Holdings Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.6; made up of an environmental score of 0.0, social score of 2.7 and governance score of 8.0.
3.6
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1132 | Taro Pharmaceutical Industries Ltd | 3.7 | Medium |
| 1132 | Traphaco JSC | 3.7 | Medium |
| 1144 | Sonnet Biotherapeutics Holdings Inc | 3.6 | Medium |
| 1144 | CellSeed Inc | 3.6 | Medium |
| 1144 | Cellectar Biosciences Inc | 3.6 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Sonnet Biotherapeutics Holdings Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Sonnet Biotherapeutics Holdings Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Sonnet Biotherapeutics Holdings Inc report the average age of the workforce?
Sign up for free to unlockDoes Sonnet Biotherapeutics Holdings Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Sonnet Biotherapeutics Holdings Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Sonnet Biotherapeutics Holdings Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Sonnet Biotherapeutics Holdings Inc offer flexible work?
Sign up for free to unlockDoes Sonnet Biotherapeutics Holdings Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Sonnet Biotherapeutics Holdings Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Sonnet Biotherapeutics Holdings Inc conduct supply chain audits?
Sign up for free to unlockDoes Sonnet Biotherapeutics Holdings Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Sonnet Biotherapeutics Holdings Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Sonnet Biotherapeutics Holdings Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Sonnet Biotherapeutics Holdings Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Sonnet Biotherapeutics Holdings Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Sonnet Biotherapeutics Holdings Inc disclose water use targets?
Sign up for free to unlockDoes Sonnet Biotherapeutics Holdings Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Sonnet Biotherapeutics Holdings Inc have a product recall in the last two years?
Sign up for free to unlockDoes Sonnet Biotherapeutics Holdings Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Sonnet Biotherapeutics Holdings Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Sonnet Biotherapeutics Holdings Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Sonnet Biotherapeutics Holdings Inc disclose parental leave metrics?
Sign up for free to unlockDoes Sonnet Biotherapeutics Holdings Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Sonnet Biotherapeutics Holdings Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Sonnet Biotherapeutics Holdings Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Sonnet Biotherapeutics Holdings Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Sonnet Biotherapeutics Holdings Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Sonnet Biotherapeutics Holdings Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Sonnet Biotherapeutics Holdings Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Sonnet Biotherapeutics Holdings Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Sonnet Biotherapeutics Holdings Inc disclose its waste policy?
Sign up for free to unlockDoes Sonnet Biotherapeutics Holdings Inc report according to TCFD requirements?
Sign up for free to unlockDoes Sonnet Biotherapeutics Holdings Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Sonnet Biotherapeutics Holdings Inc disclose energy use targets?
Sign up for free to unlockDoes Sonnet Biotherapeutics Holdings Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Sonnet Biotherapeutics Holdings Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Sonnet Biotherapeutics Holdings Inc
These potential risks are based on the size, segment and geographies of the company.
Sonnet BioTherapeutics Holdings, Inc., a clinical stage oncology-focused biotechnology company, develops platform for biologic medicines of single or bispecific action. The company develops fully human albumin binding technology, which utilizes human single chain antibodies fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its lead candidate is SON-1010, a fully human version of interleukin 12 for the treatment non-small cell lung cancer, and head and neck cancer. The company is also developing SON-080, a fully human version of interleukin 6 for chemotherapy-induced peripheral neuropathy and diabetic peripheral neuropathy. It has a license agreement with New Life Therapeutics PTE, LTD. to develop and commercialize pharmaceutical preparations containing a specific recombinant human interleukin 6. Sonnet BioTherapeutics Holdings, Inc. is based in Princeton, New Jersey.